Bone mass density in lean and overweight women with polycystic ovary syndrome

References

• Glintborg D, Hermann AP, Andersen M. Bone mineral density and vitamin D in PCOS and hirsutism. Expert Rev Endocrinol Metab. 2013;8(5):449–459.
   PubMedGoogle Scholar
• Azziz R, Carmina E, Chen Z, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47.
   PubMed Web of Science ®Google Scholar
• Krishnan A, Muthusami S. Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol. 2017;232(2):R99–R113.
   PubMed Web of Science ®Google Scholar
• Rubin KH, Glintborg D, Nybo M, et al. Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study. J Bone Miner Res. 2016;31(4):709–717.
   PubMed Web of Science ®Google Scholar
• Cooney LG, Dokras A. Beyond fertility: polycystic ovary syndrome and long-term health. Fertil Steril. 2018;110(5):794–809.
   PubMed Web of Science ®Google Scholar
• Neven ACH, Laven J, Teede HJ, et al. A summary on polycystic ovary syndrome: diagnostic criteria, prevalence, clinical manifestations, and management according to the latest international guidelines. Semin Reprod Med. 2018;36(1):5–12.
   PubMed Web of Science ®Google Scholar
• Marshall JC, Dunaif A. Should all women with PCOS be treated for insulin resistance? Fertil Steril. 2012;97(1):18–22.
   PubMed Web of Science ®Google Scholar
• Goyal M, Dawood AS. Debates regarding lean patients with polycystic ovary syndrome: a narrative review. J Hum Reprod Sci. 2017;10(3):154–161.
   PubMedGoogle Scholar
• Ganie MA, Chakraborty S, Sehgal A, et al. Bone mineral density is unaltered in women with polycystic ovary syndrome. Horm Metab Res. 2018;50(10):754–760.
   PubMed Web of Science ®Google Scholar
• Piovezan JM, Premaor MO, Comim FV. Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis. Hum Reprod Update. 2019;25(5):633–645.
   PubMed Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.
   PubMed Web of Science ®Google Scholar
• Cauley JA. Estrogen and bone health in men and women. Steroids. 2015;99*(Pt A):11–15.
   PubMedGoogle Scholar
• Karadağ C, Yoldemir T, Gogas Yavuz D. Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients. Gynecol Endocrinol. 2017;33(3):234–237.
   PubMed Web of Science ®Google Scholar
• Katulski K, Slawek S, Czyzyk A, et al. Bone mineral density in women with polycystic ovary syndrome. J Endocrinol Invest. 2014;37(12):1219–1224.
   PubMed Web of Science ®Google Scholar
• Garg D, Merhi Z. Advanced glycation end products: link between diet and ovulatory dysfunction in PCOS? Nutrients. 2015;7(12):10129–10144.
   PubMed Web of Science ®Google Scholar
• Niethammer B, Körner C, Schmidmayr M, et al. Non-reproductive effects of anovulation: bone metabolism in the luteal phase of premenopausal women differs between ovulatory and anovulatory cycles. Geburtshilfe Frauenheilkd. 2015;75(12):1250–1257.
   PubMed Web of Science ®Google Scholar
• Ouyang F, Wang X, Arguelles L, et al. Menstrual cycle lengths and bone mineral density: a cross-sectional, population-based study in rural Chinese women ages 30–49 years. Osteoporos Int. 2007;18(2):221–233.
   PubMed Web of Science ®Google Scholar
• Prior JC, Vigna YM, Schechter MT, et al. Spinal bone loss and ovulatory disturbances. N Engl J Med. 1990;323(18):1221–1227.
   PubMed Web of Science ®Google Scholar
• Li D, Hitchcock CL, Barr SI, et al. Negative spinal bone mineral density changes and subclinical ovulatory disturbances-prospective data in healthy premenopausal women with regular menstrual cycles. Epidemiol Rev. 2014;36:137–147.
   PubMedGoogle Scholar
• Svendsen PF, Nilas L, Nørgaard K, et al. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Hum Reprod. 2008;23(9):2113–2121.
   PubMed Web of Science ®Google Scholar
• Aziz M, Wissing ML, Naver KV, et al. Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40. Gynecol Endocrinol. 2014;30(4):311–315.
   PubMed Web of Science ®Google Scholar
• Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–1470.
   PubMed Web of Science ®Google Scholar
• Knopp JL, Holder-Pearson L, Chase JG. Insulin units and conversion factors: a story of truth, boots, and faster half-truths. J Diabetes Sci Technol. 2019;13(3):597–600.
   PubMedGoogle Scholar
• Bartsch W. Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men. Maturitas. 1980;2(2):109–118.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672.
   PubMed Web of Science ®Google Scholar
• Yüksel O, Dökmetaş HS, Topcu S, et al. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab. 2001;19(4):257–262.
   PubMed Web of Science ®Google Scholar
• Carmina E, Guastella E, Longo RA, et al. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):583–589.
   PubMed Web of Science ®Google Scholar
• Ho-Pham LT, Nguyen UD, Nguyen TV. Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2014;99(1):30–38.
   PubMed Web of Science ®Google Scholar
• Banting LK, Gibson-Helm M, Polman R, et al. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51.
   PubMed Web of Science ®Google Scholar